1. 転職サイト ビズリーチ
  2.  > 
  3. 求人検索
  4.  > 【アステラス製薬株式会社】Congress Lead
  5.  >  Early Scientific Engagement and Communication

転職・求人情報の詳細をご覧になる場合は会員登録（無料）が必要です

新規会員登録（無料）

【アステラス製薬株式会社】Congress Lead, Early Scientific Engagement and Communication

年収： 800万 ～ 1100万 ?

採用企業案件

採用企業

アステラス製薬株式会社

  • 東京都

    • 資本金103,001百万円
    • 会社規模5001人以上
  • 医薬品メーカー
部署・役職名 【アステラス製薬株式会社】Congress Lead, Early Scientific Engagement and Communication
職種
業種
勤務地
仕事内容 当社は日本発のグローバル製薬メーカーとして、日本を中心に米州・欧州・アジア・オセアニアに拠点を構え、先端・信頼の医薬で、「世界の人々の健康に貢献する」という経営理念の下、イノベーションを継続的に創出し、患者さんのニーズに応える革新的な医療ソリューションを届けていくという一貫した姿勢で歩んでおります。
変化する医療の最先端に立ち、科学の進歩を患者さんの価値に変えていくことで、ステークホルダーや社会からの期待に応え続けます。

【Purpose ＆ Scope】
Early Scientific Engagement & Communications Lead will support the strategic development and execution of scientific communications for oncology-focused early-stage assets, ensuring alignment with the broader global oncology portfolio strategy. Reporting to the Head of Early Scientific Engagement and Communications, this Japan-based role is positioned within the Quantitative Sciences & Evidence Generation (QSEQ) function. This enables a data-driven, evidence-backed approach that integrates biostatistics, real-world evidence (RWE), epidemiology, and medical writing to shape compelling scientific narratives for oncology research assets originating from or relevant to the Japan region.
A core focus of this role is to support the initiation of scientific narratives for oncology assets beginning at the discovery and pre-clinical stages, working closely with Japan Oncology Research and Development leads. The role will leverage existing global Scientific Platforms and processes to ensure regional activities are aligned with global strategies. This position will be instrumental in driving early data dissemination within the Japan context, providing tactical support to global and regional Asset Maximization Teams (AMTs) to ensure the early-phase oncology portfolio is positioned effectively for regional needs. Collaboration with Japan Corporate Communications and regional leadership will be essential to align external messaging for early-stage assets with global strategy.
This role will work in close partnership with global and regional Scientific Publications teams, ensuring that the scientific communication strategy for early-stage oncology assets is seamlessly integrated within the broader pipeline strategy and adapted for regional scientific discourse.


【Essential Job Responsibilities】
Oncology Research-Focused Scientific Engagement & Strategic Communications (Japan Support)
· Support the development of scientific narratives for early-stage oncology assets in partnership with Japan and global Oncology Research leads, ensuring alignment with the broader global scientific strategy and corporate narrative.
· Execute strategic scientific messaging for oncology assets from drug discovery through Proof of Concept (POC), with a focus on relevance for the Japan research environment and scientific community.
· Provide tactical support to global and regional AMTs on early data dissemination plans, ensuring alignment with asset development and communication strategies for the Japan region.
· Partner with Japan Corporate Communications to integrate early-stage scientific messaging into regional external engagement strategies, ensuring alignment with global guidance.
· Collaborate with global and regional Scientific Publications teams to align on scientific communication platforms, ensuring a unified strategy for the early oncology pipeline.
· Support the integration of early-phase scientific communication with data-driven insights by liaising with QSEQ’s biostatistics, RWE, and epidemiology teams to contribute to evidence-backed communication materials.

Oncology Early Pipeline Publications & Content Strategy (Regional Execution)
· Support the implementation of global publication plans to ensure early-phase oncology assets are strategically positioned in regional and global scientific discourse.
· Assist in developing and executing publication strategies in collaboration with Subject Matter Experts (SMEs) within Japan R&D for early-phase pipeline publications.
· Leverage established global scientific platforms to enhance publications and optimize content for potential re-use in regional contexts.
· Ensure regional publication activities align with evolving scientific data and global early clinical development priorities.

Content Development & Scientific Communications Support
· Develop and adapt centralized scientific content for early-phase oncology assets to support regional Medical Information and Medical Education functions in Japan.
· Support Japan Medical Information content review for early pipeline scientific accuracy and consistency.
· Assist in guiding digital publication enhancements and publication extenders for early-phase oncology assets in the region.

Cross-Functional Collaboration & Stakeholder Engagement
· Ensure close collaboration with Japan and global Scientific Publications teams while maintaining a distinct focus on early-stage asset communications.
· Engage with Japan clinical, regulatory, and research teams to ensure that early-phase scientific insights are strategically communicated and aligned across functions.
· Represent the Japan early scientific engagement activities in internal discussions, contributing to strategic alignment between regional and global pipeline development efforts.

This position reports to an Executive Director.
This position is an individual contributor role.
This position is a hybrid position.
This position is part of the Quantitative Sciences and Evidence Generations group. Cell and Gene Therapy & Biopharma, or Exploratory statistics in SRS
労働条件 【勤務開始日 / Start Date】
応相談
Will be decided according to the candidate's flexibility

【契約期間 / Contract Duration】
期間の定めなし
Not limited to specified period

【試用期間 / Probation Period】
試用期間原則なし
No probation period in principle

【給与 / Salary】
①基本給：当人の経歴・技術・技能等を考慮して決定
②裁量労働制の場合：裁量労働手当として職務グレードに応じて50,000～100,000円支給
①Base salary: will be decided by the candidate's experience, skill and capability.
②When Discretionary Work System is applied: Discretionary work allowance will be paid.(50,000～100,000yen, based on the Grade)

【昇給 / Salary Raise】
有り

【賞与 / Bonus】
有り

【諸手当 / Allowance】
裁量労働手当、住宅手当、通勤手当　等
Discretionary work allowance, Housing allowance, Commutation allowance, etc.

【勤務時間 / Working Hours】
8:45～17:45（月～木）、8:45～16:00（金）
裁量労働制の場合、所定労働時間を働いたものとみなす
8:45～17:45（Mon～Thu）、8:45～16:00（Fri）
Discretionary Work System

【休日 / Holidays】
完全週休２日制（土曜・日曜）、祝日、5月1日、夏季、年末年始
Weekends(Sat and Sun), holidays, May 1st, summer vacation, New Year holidays

【休暇 / Vacation Leave】
年次有給休暇、育児休業制度、介護休業制度　等
Annual paid leave, childcare leave system, nursing care leave system, etc.

【福利厚生 / Welfare】
雇用保険、労災保険、厚生年金、健康保険、共済会制度、社宅制度、持株会制度、財形貯蓄制度　等
Employment Insurance, Industrial Accident Compensation Insurance, Welfare Pension Insurance, Health Insurance, Mutual Aid Association System, Company Housing System, Employee Shareholder Association System, Property Accumulation Savings System
応募資格

【必須（MUST）】

· Advanced degree (MS, PhD, PharmD, or MD) in Life Sciences, Oncology, or a related field.
· 5+ years of experience in scientific communications, medical affairs, publications, or a related role within the pharmaceutical or biotech industry, with a focus on oncology.
· Experience in early-phase drug development and scientific engagement, preferably within a Japan or global context.
· Understanding of publication planning and execution, particularly for early-stage assets.
· Proven ability to collaborate effectively with cross-functional teams, including research, clinical development, and communications.
· Excellent scientific writing, presentation, and stakeholder engagement skills in both Japanese and English.
· Strong organizational and project management skills, with the ability to manage multiple priorities.
· Ability to translate complex scientific data into clear and impactful communication materials.




【歓迎（WANT）】

· 8+ years of relevant experience in oncology-focused scientific communications.
· Experience working in a global matrix organization and navigating regional/global dynamics.
· Experience supporting or working with research teams in a discovery or translational science setting.
· Familiarity with the Japan pharmaceutical industry landscape and key scientific audiences.
· Flexibility to travel domestically and internationally as needed.
This Japan-based role is critical for ensuring regional scientific insights are integrated into the global narrative for Astellas’ early oncology pipeline, enabling effective, evidence-backed communication that supports value creation in the Japan market and beyond.
アピールポイント 自社サービス・製品あり 日系グローバル企業 女性管理職実績あり 上場企業 従業員数1000人以上 シェアトップクラス 創立30年以上 年間休日120日以上 産休・育休取得実績あり 教育・研修制度充実 完全土日休み
リモートワーク

可

「可」と表示されている場合でも、「在宅に限る」「一定期間のみ」など、条件は求人によって異なります
受動喫煙対策

屋内禁煙
更新日 2026/03/31
求人番号 7905432

採用企業情報

アステラス製薬株式会社
  • アステラス製薬株式会社

  • 東京都

    • 資本金103,001百万円
    • 会社規模5001人以上
  • 医薬品メーカー

  • 会社概要

    【創業】1923年4月
    【代表者】岡村　直樹
    【資本金】1,030億100万円
    【従業員数】13,643名 （2025年3月期末時点、連結ベース）
    【本社所在地】東京都中央区日本橋本町2-5-1

    【事業内容】医薬品の製造・販売および輸出入

転職・求人情報の詳細をご覧になる場合は会員登録（無料）が必要です

新規会員登録（無料）